Silvia Sabbioni Department of Life Sciences and Biotechnology University of Ferrara Biography Publications Institution JoVE Articles Silvia Sabbioni has not added a biography. If you are Silvia Sabbioni and would like to personalize this page please email our Author Liaison for assistance. Publications Over-expression of the MiR-483-3p Overcomes the MiR-145/TP53 Pro-apoptotic Loop in Hepatocellular Carcinoma Oncotarget. Apr, 2016 | Pubmed ID: 27120784 Prediction of Response to Anti-EGFR Antibody-based Therapies by Multigene Sequencing in Colorectal Cancer Patients BMC Cancer. 2015 | Pubmed ID: 26508446 Epstein-Barr Virus MicroRNAs Are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival EBioMedicine. Jun, 2015 | Pubmed ID: 26288818 Diagnostic and Prognostic MicroRNAs in the Serum of Breast Cancer Patients Measured by Droplet Digital PCR Biomarker Research. 2015 | Pubmed ID: 26120471 MiR-181b As a Therapeutic Agent for Chronic Lymphocytic Leukemia in the Eµ-TCL1 Mouse Model Oncotarget. Aug, 2015 | Pubmed ID: 26090867 Inhibiting the Oncogenic Mir-221 by MicroRNA Sponge: Toward MicroRNA-based Therapeutics for Hepatocellular Carcinoma Gastroenterology and Hepatology from Bed to Bench. 2014 | Pubmed ID: 25436097 MicroRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Aug, 2014 | Pubmed ID: 24916701 P53/mdm2 Feedback Loop Sustains MiR-221 Expression and Dictates the Response to Anticancer Treatments in Hepatocellular Carcinoma Molecular Cancer Research : MCR. Feb, 2014 | Pubmed ID: 24324033 Anti-tumor Activity of a MiR-199-dependent Oncolytic Adenovirus PloS One. 2013 | Pubmed ID: 24069256 Role of MicroRNAs in Hepatocellular Carcinoma: a Clinical Perspective OncoTargets and Therapy. 2013 | Pubmed ID: 24039437 MiR-221 Affects Multiple Cancer Pathways by Modulating the Level of Hundreds Messenger RNAs Frontiers in Genetics. 2013 | Pubmed ID: 23630541 Liver Tumorigenicity Promoted by MicroRNA-221 in a Mouse Transgenic Model Hepatology (Baltimore, Md.). Sep, 2012 | Pubmed ID: 22473819 In Hepatocellular Carcinoma MiR-519d is Up-regulated by P53 and DNA Hypomethylation and Targets CDKN1A/p21, PTEN, AKT3 and TIMP2 The Journal of Pathology. Jul, 2012 | Pubmed ID: 22262409 MINT31 Methylation in Gastric Noninvasive Neoplasia: Potential Role in the Secondary Prevention of Gastric Cancer European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP). Sep, 2012 | Pubmed ID: 22179688 MicroRNA Involvement in Hepatocellular Carcinoma Anti-cancer Agents in Medicinal Chemistry. Jul, 2011 | Pubmed ID: 21554203 MicroRNA Response to Environmental Mutagens in Liver Mutation Research. Dec, 2011 | Pubmed ID: 21514310 MicroRNA-221 Targets Bmf in Hepatocellular Carcinoma and Correlates with Tumor Multifocality Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Aug, 2009 | Pubmed ID: 19671867 MiR-122/cyclin G1 Interaction Modulates P53 Activity and Affects Doxorubicin Sensitivity of Human Hepatocarcinoma Cells Cancer Research. Jul, 2009 | Pubmed ID: 19584283 MicroRNA Expression Changes During Human Leukemic HL-60 Cell Differentiation Induced by 4-hydroxynonenal, a Product of Lipid Peroxidation Free Radical Biology & Medicine. Jan, 2009 | Pubmed ID: 19022373 MicroRNA Involvement in Hepatocellular Carcinoma Journal of Cellular and Molecular Medicine. Dec, 2008 | Pubmed ID: 19120703 Open Letter to Senator Rita Levi-Montalcini Science (New York, N.Y.). Mar, 2008 | Pubmed ID: 18356504 Simian Virus 40 in Humans Infectious Agents and Cancer. 2007 | Pubmed ID: 17620119 Cyclin G1 is a Target of MiR-122a, a MicroRNA Frequently Down-regulated in Human Hepatocellular Carcinoma Cancer Research. Jul, 2007 | Pubmed ID: 17616664 MicroRNAs in Human Cancer: from Research to Therapy Journal of Cell Science. Jun, 2007 | Pubmed ID: 17515481 Nidogen 1 and 2 Gene Promoters Are Aberrantly Methylated in Human Gastrointestinal Cancer Molecular Cancer. 2007 | Pubmed ID: 17328794 BK Virus, JC Virus and Simian Virus 40 Infection in Humans, and Association with Human Tumors Advances in Experimental Medicine and Biology. 2006 | Pubmed ID: 16626046 MicroRNA Gene Expression Deregulation in Human Breast Cancer Cancer Research. Aug, 2005 | Pubmed ID: 16103053 Frequent Aberrant Methylation of the CDH4 Gene Promoter in Human Colorectal and Gastric Cancer Cancer Research. Nov, 2004 | Pubmed ID: 15548679 Simian Virus 40 Infection in Humans and Association with Human Diseases: Results and Hypotheses Virology. Jan, 2004 | Pubmed ID: 15015494 Multigene Methylation Analysis of Gastrointestinal Tumors: TPEF Emerges As a Frequent Tumor-specific Aberrantly Methylated Marker That Can Be Detected in Peripheral Blood Molecular Diagnosis : a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology. 2003 | Pubmed ID: 15068392 Circulerende MicroRNA Kwantificering Met behulp van DNA-bindende Dye Chemistry and Droplet Digital PCR Manuela Ferracin1, Irene Salamon2, Laura Lupini2, Elena Miotto2, Silvia Sabbioni3, Massimo Negrini4 1Department of Experimental, Diagnostic and Specialty Medicine - DIMES, University of Bologna, 2Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, 3Department of Life Sciences and Biotechnology, University of Ferrara, 4Department of Morphology, Surgery and Experimental Medicine and Laboratory for Technologies of Advanced Therapies (LTTA), University of Ferrara Bioengineering
Circulerende MicroRNA Kwantificering Met behulp van DNA-bindende Dye Chemistry and Droplet Digital PCR Manuela Ferracin1, Irene Salamon2, Laura Lupini2, Elena Miotto2, Silvia Sabbioni3, Massimo Negrini4 1Department of Experimental, Diagnostic and Specialty Medicine - DIMES, University of Bologna, 2Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, 3Department of Life Sciences and Biotechnology, University of Ferrara, 4Department of Morphology, Surgery and Experimental Medicine and Laboratory for Technologies of Advanced Therapies (LTTA), University of Ferrara Bioengineering
